2024
DOI: 10.1055/s-0044-1780507
|View full text |Cite
|
Sign up to set email alerts
|

Venous Thrombosis in Airborne Viral Infections: Is Coronavirus Disease 2019 now Any Different from Influenza?

Giuseppe Lippi,
Emmanuel J. Favaloro,
Riccardo Nocini

Abstract: One of the hallmarks of coronavirus disease 2019 (COVID-19), particularly in complicated cases (i.e., requiring hospitalization or intensive care support), is persistent hemostasis activation, which may be associated with a vast array of thrombotic episodes involving both the arterial and venous systems. The renewed emphasis on the relationship between viral infections and venous thrombosis paves the way for determining whether a more common and often underestimated infection disease, such as influenza, may al… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 40 publications
0
1
0
Order By: Relevance
“…4 Lippi et al are here addressing the question whether the risk of thromboembolism is higher with COVID-19 than with other airborne virus infections. 5 The answer is Yes and No, depending on the strain of the influenza virus and how ill the patient gets. Regarding COVID-19, the absolute number of patients developing thromboembolism has decreased, but for the few with severe illness, typically managed in a critical care setting, the risk is still high.…”
Section: Alan Kay Computer Scientistmentioning
confidence: 99%
“…4 Lippi et al are here addressing the question whether the risk of thromboembolism is higher with COVID-19 than with other airborne virus infections. 5 The answer is Yes and No, depending on the strain of the influenza virus and how ill the patient gets. Regarding COVID-19, the absolute number of patients developing thromboembolism has decreased, but for the few with severe illness, typically managed in a critical care setting, the risk is still high.…”
Section: Alan Kay Computer Scientistmentioning
confidence: 99%